diligence, final board approval and certain other conditions. Novelda has built a strong technology position in ultra-wideband, which is complementary to Nordic’s world leading wireless technologies.

To subscribe to Press releases from this issuer, visit the Subscription to Company news section in your account section or create an account.

in connection with the Private Placement. Advokatfirmaet Thommessen AS is acting as legal counsel to the Company in connection with the Private Placement.

(North Sea), Ltd. through a Merger (as defined in the referred announcement). Following the share issue pertaining to the Merger, the issued share capital of the Company is USD 2,556,908.81, divided ...

10,000 shares in Arctic Bioscience at an average price of NOK 2,86 per share. Following the transaction, Runhild Gammelsæter holds 34,774 shares in Arctic Bioscience. Please refer to the attached ...

third quarter 2024 financial results on Wednesday, 30 October 2024.

excluding the Oseberg optional contract.

Attachment: An overview of all the completed transactions under the program for NORSK HYDRO, Norsk Hydro ASA 17/24 2,50%, Norsk Hydro ASA 20/26 FRN, Norsk Hydro ASA 20/27 4,00%, Norsk Hydro ASA 20/30 ...

(“The Company”) announced its plan to buy up to 1,629,741 own shares for a total maximum NOK 50 million. In week 41 2024, The company purchased 8,619 shares at an average price of NOK 58.0528 per ...

advisor of the following legal entities: o Aurelius Opportunities Fund IV, Ltd. o Aurelius Long-Term Opportunities Fund, Ltd. o Aurelius Opportunities Fund II, Ltd. o Anastasius LLC This disclosure is ...

5,000 shares in Arctic Bioscience at an average price of NOK 3,08 per share. Following the transaction, Gold Coast Nutrition holds 455,000 shares in Arctic ...

acquisition of 100% of Bazoom Group Aps (“Bazoom”) and Infosoft AS (“Infosoft”).